NL-OMON29157招募中不适用
A PROspective, explorative cohort study to correlate CARdiac BIomarkers with late cardiac toxicity induced by radiotherapy alone or combined with anthracycline chemotherapy for hodgkin lymphoma (PROCARBI)
Department of radiotherapy and cardiology of Erasmus MC0 个研究点目标入组 200 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Previous history of Hodgkin or mediastinal non-Hodgkin lymphoma treated with mediastinal radiotherapy with or without anthracycline-containing chemotherapy
- •Planned visit at the BETER clinic
- •Written informed consent
- •Age >= 18 years
- •A minimum of 5 years of disease free survival
排除标准
- •Not currently under treatment for malignant disease (unless basal cell carcinoma).
- •Patients who already underwent a surgical intervention for cardiac problems, such as heart valve replacement or a coronary artery bypass grafting (CABG).
研究者
相似试验
尚未招募
不适用
A PROspective, explorative cohort study to correlate CARdiac BIomarkers with late cardiac toxicity induced by radiotherapy alone or combined with anthracycline chemotherapy for hodgkin lymphoma (PROCARBI)NL-OMON46393Erasmus MC, Universitair Medisch Centrum Rotterdam200
招募中
不适用
A prospective cohort study regarding the correlation between gastrointestinal cancer and life-style related diseasesEsophageal cancer, Gastric cancer, Liver cancer, Colorectal cancer, Pancreatic cancer, Biliary cancer, disease in GI tractJPRN-UMIN000016748Gifu University Graduate School of Medicine, Gastroenterology4,000
尚未招募
不适用
A prospective, explorative cohort study to identify biomarkers of treatment response in oropharyngeal cancer.Oropharyngeal cancerNL-OMON27421Erasmus MC200
招募中
不适用
The prospective cohort study investigating the relationship between circulating CD271-positive mononuclear cells in acute coronary syndrome and secondary coronary eventsAcute coronary syndromeJPRN-UMIN000026512Kanazawa University100
进行中（未招募）
1 期
An exploratory, observational cohort study investigating commercially available treatments which may reduce the scab stage of recurrent herpes labialisEUCTR2005-001384-60-GBGlaxoSmithKline Consumer Healthcare36